Here we describe a protocol for the generation of amyloid aggregates of target amyloidogenic proteins using a bacteria-based system called curli-dependent amyloid generator (c-DaG). c-DaG relies on the natural ability of Escherichia coli cells to elaborate surface-associated amyloid fibers known as curli. an n-terminal signal sequence directs the secretion of the major curli subunit csga. the transfer of this signal sequence to the n terminus of heterologous amyloidogenic proteins similarly directs their export to the cell surface, where they assemble as amyloid fibrils. notably, protein secretion through the curli export pathway facilitates acquisition of the amyloid fold specifically for proteins that have an inherent amyloid-forming propensity. thus, c-DaG provides a cell-based alternative to widely used in vitro assays for studying amyloid aggregation, and it circumvents the need for protein purification. In particular, c-DaG provides a simple method for identifying amyloidogenic proteins and for distinguishing between amyloidogenic and non-amyloidogenic variants of a particular protein. once the appropriate vectors have been constructed, results can be obtained within 1 week.
IntroDuctIon
Many bacteria elaborate extracellular amyloid fibers that contribute substantially to biofilm formation 1 . In E. coli, these fibers, known as curli, assemble from two related amyloidogenic proteins, the fully secreted major subunit CsgA and the surface-anchored minor subunit CsgB (refs. 1,2). The bipartite signal sequence that directs these proteins to the cell surface consists of 20 N-terminal residues that direct them across the inner membrane via the general Sec translocon, followed by 22 residues that direct them through a curli-specific pore-like structure in the outer membrane that is formed by the CsgG protein 3 . Whereas the Sec signal sequence is removed during translocation across the inner membrane, the 22-residue CsgG targeting sequence is retained at the N terminus of the mature CsgA and CsgB proteins 3 . When appropriately transferred, this CsgG targeting sequence can also direct the secretion of proteins that are normally retained in the periplasm 4 . Although curli biogenesis ordinarily depends on several curli-specific accessory proteins, CsgG overproduction in the absence of these accessory factors enables the efficient secretion of CsgA 2, 3, 5 .
By using a set of test proteins from yeast, humans and bacteria, we have previously shown that the curli export system can be appropriated for the production of extracellular amyloid fibrils composed of heterologous amyloidogenic proteins 5 . The system, which we call C-DAG, facilitates acquisition of the amyloid fold specifically for proteins that have an inherent amyloid-forming propensity, as demonstrated using various non-amyloidogenic proteins that served as negative controls 5 . C-DAG has three components: an E. coli strain that is deleted for the csgA and csgB genes, a plasmid that directs the inducible overproduction of CsgG and a compatible plasmid that directs the inducible synthesis of an epitope-tagged target protein fused to the CsgA signal sequence (CsgA ss ). To induce fibril production, the cells are plated on solid medium containing inducers for both CsgG and the target fusion protein 5 . After several days of growth, the colonies and any extracellular aggregates are scraped off of the plates and the scraped cell suspension is examined for the presence of amyloid material. Fibers can typically be visualized by transmission electron microscopy (TEM) 5 . A diagnostic feature of most amyloid aggregates is their resistance to denaturation in the presence of SDS, and SDS-stable aggregates of the target protein can be detected using a convenient filter-retention assay 5 . With many (though not all) target proteins, the presence of extracellular amyloid aggregates can also be detected by including the amyloid-binding dye Congo red (CR) in the medium. Similarly to curli-positive cells of wild-type E. coli 2 , cells programmed to export a diverse set of amyloidogenic proteins form bright red colonies on this medium 5 . For those aggregates that stain efficiently with CR, the material can be examined by bright-field microscopy between crossed polarizers to detect the 'apple-green' birefringence that is diagnostic of amyloid material 5 .
Applications of C-DAG
In its most straightforward application, C-DAG can be used to test particular target proteins for their amyloid-forming propensities. Furthermore, the system can be used to identify mutations that modulate target protein amyloidogenicity, as evidenced by our demonstration that C-DAG can distinguish variants of a single protein that show different degrees of amyloidogenicity 5 . For proteins that bind CR when assembled as amyloid aggregates, such mutations can readily be identified by screening for the appropriate colony-color phenotype (either redder colonies or paler colonies, for mutations that facilitate or inhibit amyloid conversion, respectively). Similarly, C-DAG can be used to test small molecules or other agents for their abilities to hinder or accelerate amyloid conversion for specific target proteins. It should also be feasible to screen libraries of small molecules for those that modulate the conversion process, again particularly for proteins that bind CR when they are assembled as amyloid aggregates.
Other potential applications include screening open reading frame (ORF), genomic or cDNA libraries to identify amyloidogenic proteins. We have previously established the feasibility of using C-DAG to identify amyloidogenic proteins by performing a pilot screen using a partial E. coli ORF library (~600 ORFs) and plating the transformed cells on solid inducing medium containing CR 5 .
By selecting healthy colonies that stained a particularly bright shade of red, we identified a protein that had previously been shown to assemble as amyloid fibers in vitro. However, previous reports have documented the ability of CR to bind material that is not necessarily amyloid 6 . Indeed, this lack of specificity is consistent with our own unpublished data, which indicate that large numbers of transformants stain various shades of red on this medium in the absence of detectable amyloid aggregates. The detailed explanation for this apparently spurious staining is unclear at present. Thus, although CR is clearly useful for studying specific amyloidogenic proteins, we do not currently recommend using CR for large-scale screens owing to the high potential rate of false positives. Ongoing work in our laboratory is directed at developing an alternative plate-based visual assay for detecting colonies in which the cells are producing extracellular amyloid aggregates. In lieu of a more facile assay, we have found that the filter-retention assay can be used to identify colonies of interest.
Advantages of C-DAG
C-DAG provides a convenient, cell-based alternative to widely used in vitro assays for studying amyloid aggregation (for examples, see refs. 7, 8) . Such assays require that the protein of interest (POI) be purified before its aggregation is monitored from a soluble and fully (or partially) unfolded state. The use of C-DAG circumvents the need to purify individual target proteins, as the export process mediates separation of the POI from the bulk of cellular protein, delivering it to the extracellular space in a fully or partially unfolded state that presumably facilitates amyloid assembly. Notably, C-DAG provides a broadly applicable genetic assay for studying amyloid aggregation for what appears to be a diverse set of amyloidogenic proteins. Thus, unbiased screens can be conducted to identify mutations that hinder or accelerate amyloid conversion for POIs.
As a cell-based assay, C-DAG evidently facilitates amyloid conversion for proteins that ordinarily access the amyloid conformation under restrictive conditions 5 . In the native curli system, the membrane-anchored minor subunit CsgB is required to nucleate the polymerization of the freely secreted CsgA subunit 2, 9 . However, C-DAG supports amyloid fibril formation by CsgA itself 5 , presumably because under these experimental conditions the local concentration of exported CsgA is sufficiently high to permit CsgBindependent polymerization. C-DAG also supports amyloid fibril formation by various yeast prion proteins, including the prionforming moiety of Sup35 (ref. 5) , which requires the presence of another prion to access the amyloid (prion) conformation in the native yeast system 10, 11 .
Another advantage of C-DAG is that it enables amyloid aggregation to be studied under a uniform set of conditions for multiple different amyloidogenic proteins, facilitating comparative studies on the effects of small-molecule modulators of amyloid aggregation. We note that several other cell-based systems have been developed for the discovery of modulators of amyloid aggregation, including a specialized yeast-based assay that was used to identify compounds that could cure yeast cells of two endogenous prions 12 and two bacteria-based assays that have been used to screen for inhibitors of the aggregation of the Alzheimer's amyloid-β peptide (Aβ) 13, 14 . However, the use of these bacterial systems to study amyloid aggregation in general has not been described.
Limitations of C-DAG
Although we have shown that C-DAG effectively reports on the amyloid aggregation of a variety of amyloidogenic proteins, including six yeast prion proteins, a poly-Q expansion variant of the human huntingtin protein and a bacterial flagellar protein 5 , certain amyloidogenic proteins could prove toxic when they are induced for export, thus precluding their study using C-DAG. For example, we speculate that premature aggregation of certain proteins could potentially jam the Sec translocon and/or the CsgG pore, exerting toxicity by this or another mechanism. It is also possible that certain target amyloidogenic proteins might be inefficiently produced in the bacterial system. The use of a synthetic gene that is Induction of protein production on solid medium for SDS-resistance or transmission electron microscopy analyses
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Step 13C codon-optimized for expression in E. coli could potentially ameliorate this problem. Finally, the use of C-DAG requires that the target protein be able to access the amyloid conformation when the 22-residue CsgG targeting sequence is appended at its N terminus. It is possible that certain amyloidogenic proteins will be unable to assemble when they are fused in this fashion. Similarly, it is possible that certain amyloidogenic proteins will be unable to assemble when they are provided with a C-terminal epitope tag (which is necessary for protein detection unless a specific antibody is available). In the event that a C-terminal epitope tag is not tolerated, the epitope tag could be placed between the CsgG targeting sequence and the N terminus of the native target protein.
Experimental design
To test the amyloidogenicity of a given POI using C-DAG, a vector is first constructed that encodes the POI fused to the bipartite CsgA ss (Steps 1-9). This vector is then introduced into the exporter strain and the transformants are plated on noninducing medium. At this point, isolated transformants are grown under three separate conditions, in parallel: (i) transformants are cultured and plated on inducing medium in order to assay for the presence of SDS-resistant aggregates by filter retention and/or extracellular fibrils by TEM ( Fig. 1, left) , (ii) transformants are cultured and plated on inducing medium containing CR in order to determine the colony-color phenotype, and, in addition, material obtained from the plates can be assayed for CR birefringence by bright-field microscopy ( Fig. 1 , middle); (iii) transformants are cultured and then diluted into liquid inducing medium in order to assess the relative levels of exported protein by SDS-PAGE and western blotting ( Fig. 1, right) . Taken together, the results of these various assays are used to determine whether or not the POI forms extracellular amyloid aggregates when exported via the curli pathway. For other applications of C-DAG discussed above, it may be desirable to use these assays in a hierarchical scheme rather than performing them in parallel. (Fig. 2) contains the arabinoseinducible BAD promoter controlling the expression of the csgA ss -fusion construct. A NotI restriction site located at the 3′ end of the signal sequence allows convenient cloning, and it encodes a three-alanine linker between the signal sequence and the protein selected for export. The pExport vector contains a constitutively transcribed bla gene, which provides resistance to carbenicillin and ampicillin. E. coli strains Any cloning strain can be used for standard cloning purposes and should be purchased as competent cells, or made competent before use.
MaterIals

REAGENTS
• proceDure preparing the gene of interest for cloning into the pexport vector • tIMInG 2 d-1 week 1| Attain the DNA sequence of the gene of interest (GOI) encoding the protein or peptide you wish to study (POI). In this protocol, we describe cloning using the restriction enzymes NotI and XbaI and DNA ligase, and the pExport vector (Fig. 2) .
2|
Determine whether the GOI contains NotI or XbaI restriction sites. If restriction sites for Not1 or XbaI exist, use any oligonucleotide-directed site-specific mutagenesis method (e.g., the QuickChangeII site-directed mutagenesis kit; see Reagents) to eliminate the restriction site(s) using the instructions provided by the manufacturer. If the GOI is being synthesized, ensure that no internal NotI or XbaI restriction sites are created, and take into account the codon bias in E. coli. Synthesize or PCR-amplify the GOI with the DNA sequence 5′-NNGCGGCCGCA-3′ directly upstream of the first codon of the GOI (this sequence, which contains a NotI restriction site, codes for a three-alanine linker between the CsgA signal sequence and your POI) and the DNA sequence 5′-TCTAGANN-3′ downstream of the STOP codon of the GOI (this sequence contains an XbaI restriction site). To facilitate downstream analysis, an epitope tag can be introduced at the 3′ end of the GOI preceding the STOP codon. In this protocol, we use a His 6 tag.
cloning the GoI into the pexport vector • tIMInG 5 d-2 weeks 3| Purify the NotI-and XbaI-digested insert (GOI) and vector (pExport) by gel electrophoresis, followed by gel extraction using a gel purification kit (e.g., Zymoclean gel DNA recovery kit) according to the manufacturer's instructions.
4|
Ligate the purified insert and vector using the instructions provided with the DNA ligase.  crItIcal step Include a positive control (undigested pExport plasmid) to determine the transformation efficiency, and use two negative controls (the digested pExport vector alone, with and without ligase) to ensure that the vector was digested to completion and to determine the efficiency of insert ligation.
6|
Test transformants to ensure that clones are properly assembled. For this, select several colonies from the transformation plate and perform colony PCR with vector-specific primers that flank the GOI. We typically perform colony PCR according to the guidelines provided in a previous protocol 16 . Select candidate colonies that gave rise to a PCR-amplified fragment of the expected size, and inoculate each in 3 ml of LB medium supplemented with 100 µg ml − 1 carbenicillin and 0.5% (wt/vol) glucose, and allow them to grow at 37 °C overnight.
7|
Extract plasmid DNA from the overnight-grown cultures using any plasmid isolation method. We typically use commercially available plasmid isolation kits (e.g., Zyppy plasmid miniprep kit) according to the instructions provided by the manufacturer.
8|
Sequence the GOI in the plasmids isolated from Step 7 using vector-specific primers that flank the entire ORF, including the csgA ss . We suggest using as primers the following DNA sequences, which are located 51-and 46-bp upstream, and downstream of the entire ORF, respectively: forward primer sequence: 5′-cctgacgctttttatcg-3′; reverse primer sequence: 5′-aggctgaaaatcttctctc-3′.  crItIcal step Internal, GOI-specific primers may be required to attain full coverage of large GOIs.
9| Select a positive candidate that has a perfect copy of the entire ORF, consisting of the csgA ss , the sequence encoding the three-alanine linker and the GOI. Ensure that these three sequence elements are in frame.  pause poInt The plasmid can be stored at − 20 °C until required.
preparation of exporter cells • tIMInG 4 d (experiment continues for up to 1 week) 10| Prepare competent cells of the E. coli exporter strain VS39 (Reagent Setup).
11| Transform competent VS39 cells with the pExport plasmid containing the GOI (from Step 9) according to the transformation procedure described in ref. 13 . Plate the transformed cells on LB agar supplemented with 100 µg ml − 1 carbenicillin, 25 µg ml − 1 chloramphenicol and 0.5% (wt/vol) glucose. Incubate the transformed cells overnight at 37 °C.  crItIcal step Include pExport plasmids encoding fusion constructs that have previously been shown to form or not form extracellular amyloid aggregates using C-DAG, as positive and negative controls, respectively. We typically use Sup35 NM (residues 2-253) as our positive control and Sup35 M (residues 125-253) as our negative control 5 .
12| Select a single colony from the plate and grow it in 3 ml of LB supplemented with 100 µg ml − 1 carbenicillin and 25 µg ml − 1 chloramphenicol on a shaker, overnight at 37 °C.
Induction of protein production 13|
Depending on the downstream application, use one of the three following methods (option A, B or C) for inducing protein production (Fig. 1) . (a) on solid medium for sDs-resistance or teM analysis • tIMInG 5 d  crItIcal step Instructions for performing the succeeding SDS-resistance analysis are provided in Steps 14A and 15-21, whereas instructions for performing TEM are provided in Steps 14B and 14C.  crItIcal step Note that for some proteins aggregated material and fibers can be detected in fewer than 5 d, but the 5-d incubation period is recommended as a starting point when testing a new protein.
(i) For every POI to be tested, prepare two 'inducing plates' that contain LB agar supplemented with 100 µg ml − 1 carbenicillin, 25 µg ml − 1 chloramphenicol, 0.2% (wt/vol) L-arabinose and 1 mM IPTG, and one 'noninducing control plate' containing LB agar supplemented with 100 µg ml − 1 carbenicillin and 25 µg ml − 1 chloramphenicol. Each plate should be allowed to air-dry, upside down with the lid partially open, for 15 min at 37 °C before use. (ii) Prepare a dilution of the overnight culture from Step 12 to an optical density (OD) of 0.01 in 3 ml of LB medium supplemented with 100 µg ml − 1 carbenicillin and 25 µg ml − 1 chloramphenicol, and then incubate the diluted culture on a shaker for 30 min at 37 °C. (iii) For each sample to be tested, transfer the diluted culture as 36 individual 5-µl spots onto each of the three plates prepared in Step 13A(i). We recommend using a multichannel pipette and a 96-well microtiter plate when spotting. For this, transfer 50 µl of the diluted culture from Step 13A(ii) into six consecutive wells in a sterile 96-well microtiter plate. Use a multichannel pipette to simultaneously transfer 5 µl of the culture from each of the six wells onto the plate. Repeat this step six times using the multichannel pipette to generate a grid of six by six spots per plate. (iv) Allow the culture to be absorbed into the agar before inverting the plates and incubating them at 22 °C for 5 d.
 crItIcal step We recommend checking the plates every day to monitor growth. Comparison of bacterial growth on the noninducing control plate and the inducing plates reveals any cell toxicity that might result from the induction of fusion protein synthesis.
(B) on solid medium containing cr for colony-color phenotype or birefringence analysis • tIMInG 5 d  crItIcal step Instructions for performing the succeeding CR birefringence analysis are provided in Step 14D.  crItIcal step Note that for some proteins colony-color phenotype can readily be assessed in fewer than 5 d, but for others the 5-d incubation period is required to see the best phenotype.
(i) For every POI to be tested, prepare one 'CR inducing plate' that contains LB agar supplemented with 100 µg ml − 1 carbenicillin, 25 µg ml − 1 chloramphenicol, 0.2% (wt/vol) L-arabinose, 1 mM IPTG and 10 µg ml − 1 CR; one 'CR noninducing control plate' containing LB agar supplemented with 100 µg ml − 1 carbenicillin, 25 µg ml − 1 chloramphenicol and 10 µg ml − 1 CR; and one 'noninducing control plate' containing LB agar supplemented with 100 µg ml − 1 carbenicillin and 25 µg ml − 1 chloramphenicol. Each plate should be allowed to air-dry, upside down with the lid partially open, for 15 min at 37 °C before use. ! cautIon CR is toxic. When you are weighing out CR powder, use gloves and a dust mask. (ii) Prepare a dilution of the overnight culture from Step 12 to an OD of 0.01 in 3 ml of LB medium supplemented with 100 µg ml − 1 carbenicillin and 25 µg ml − 1 chloramphenicol; incubate the diluted culture on a shaker for 30 min at 37 °C. (iii) For each sample to be tested, transfer the diluted culture as two individual 5-µl spots onto each of the three plates prepared in Step 13B(i).  crItIcal step If several different POIs are being tested, cells expressing the different POIs can be spotted on the same plate for ease when comparing the colony-color phenotypes. (iv) Allow the culture to be absorbed into the agar before inverting the plates and incubating them at 22 °C for 5 d.
 crItIcal step We recommend checking the plates every day to monitor growth and color phenotype (Fig. 3) .
Comparison of bacterial growth on the noninducing control plates (with and without CR) and the inducing plate reveals any cell toxicity that might result from the induction of fusion protein synthesis or the presence of CR. preparation of samples for analysis 14| Depending on the downstream analysis to be performed, prepare samples from Step 13 by using one of the following options ( Fig. 1): (a) For filter-retention analysis to detect the presence of sDs-resistant aggregates • tIMInG 1 d  crItIcal step Instructions for performing the subsequent filter-retention assay are provided in Steps 15-21.
(i) For each POI, transfer 1 ml of PBS to one of two inducing plates from Step 13A(iii). Save the other inducing plate as a backup in case the procedure needs to be repeated. (ii) Resuspend the spots of bacteria by gently moving a glass or metal spreader back and forth across the plate.  crItIcal step If the PBS is quickly absorbed into the agar, add more PBS to the plate, 200 µl at a time, in order to be able to resuspend the spots of bacteria. The final volume of resuspended cells should be ~500 µl. (iii) Transfer the resuspension to a 1.5-ml microcentrifuge tube. (iv) By using PBS, prepare a dilution of the resuspension to an OD of 1.0 in a volume of 100 µl.
 crItIcal step If the OD of the prediluted sample is less than 1.0, repeat the sample preparation as described in
Step 14A(i,ii) in a smaller volume of PBS. (v) Transfer 100 µl of the diluted sample to a new 1.5-ml microcentrifuge tube. (vi) To the 100-µl sample, add 100 µl of BugBuster protein extraction reagent. Add rLysozyme and OmniCleave endonuclease to a final concentration of 300 U ml − 1 and 10 U ml − 1 , respectively. Incubate the sample at 22 °C with gentle rocking, either on a rocker or by inverting the tube once every minute. Other nonionic detergents could be substituted for BugBuster to promote cell lysis in combination with lysozyme. However, it is important to ensure that complete cell lysis is achieved, as unlysed cells will clog the membrane in Step 15. Alternative endonucleases can be used to substitute for OmniCleave endonuclease, but it is important to ensure that sufficient nuclease activity is achieved in order to reduce the viscosity of the sample. Viscous samples will clog the membrane in Step 15 and should not be used for analysis. (ix) Examine the sample on the grid for the presence of fibers using TEM (Fig. 3b) . 16| Prepare seven twofold dilutions of samples in row A in PBS supplemented with SDS to a final concentration of 2% (wt/vol), maintaining the same final sample volume in each well. For ease of analysis, dilutions for each sample should be prepared in consecutive wells in the same column as the undiluted sample.
17| By using a multichannel pipette, transfer the samples to the 96-well vacuum manifold, using the 96-well microtiter plate as a guide template.  crItIcal step Avoid introducing air bubbles in the wells of the vacuum manifold, as this can result in uneven flow of the sample through the membrane.
18|
Turn on the vacuum to draw the samples through the membrane.  crItIcal step If the sample in a given well does not get drawn through the membrane, it is likely that the sample has clogged the membrane. This well should be ignored during subsequent analysis. ? trouBlesHootInG 19| Once the samples have been drawn through the membrane, using the multichannel pipette, wash the wells of the manifold by transferring 200 µl of PBS supplemented SDS to a final concentration of 2% (wt/vol). Repeat this wash once.  crItIcal step It is important to work quickly so as not to allow air to be drawn through the membrane for more than 30 s at a given time, as this can affect protein detection and/or analysis in subsequent steps.
20|
Remove the membrane from the vacuum manifold and mark one corner of the membrane for orientation purposes.
21|
Detect the presence of SDS-resistant aggregates on the membrane by probing for the His 6 epitope using the instructions provided by the manufacturer of the His 6 antibody.
? trouBlesHootInG A common problem involves a well(s) of the dot-blot manifold becoming clogged by sample(s), resulting in a fraction of the sample(s) being retained in the well. Membrane clogging can be caused by: (i) incomplete cell lysis, wherein unlysed cells are retained on the filter and prevent passage of the remaining sample through the membrane, (ii) inadequate endonuclease activity, resulting in a sample that is too viscous to pass through the membrane, and (iii) large amounts of SDS-resistant aggregates being retained on the membrane and preventing passage of the remaining sample through the membrane.
In most cases, assuming that there is sufficient SDS-resistant aggregated material retained on the membrane for subsequent detection, membrane clogging can be overcome by diluting the sample. Therefore, we suggest using multiple dilutions in Step 16. To determine the reason(s) for membrane clogging and to facilitate subsequent analysis, we recommend, as described in Step 11, always to include control POIs that have previously been shown using C-DAG to form or not form extracellular amyloid aggregates, respectively.
Membrane clogging by the negative control sample suggests incomplete cell lysis or inadequate endonuclease activity. The concentration of lysozyme and/or nucleases used in Step 14A(vi) can be increased without affecting subsequent analysis. The optimal amount of enzyme should be predetermined by testing varying concentrations of enzyme without altering the incubation time, particularly if you are using alternative lysis reagents, and it should be applied to all samples equally. Membrane clogging by the positive control but not the negative control suggests that too much SDS-resistant aggregated material is being retained. In this case, there is no need to change the lysis procedure. The use of diluted samples, as instructed in Step 16, will suffice (Fig. 4) .
We do not recommend prolonging the incubation period for cell lysis, as it is important to minimize the amount of amyloid aggregates that might be formed during the incubation period. We also do not recommend pelleting cellular debris by low-speed centrifugation, as this may result in co-pelleting of aggregates.
• tIMInG Steps 1 and 2, preparation of the GOI for cloning into pExport vector: 2 d-1 week Steps 3-9, cloning the GOI into the pExport vector: 5 d-2 weeks Steps 10-12, preparation of exporter cells: 4d, and experiment continues for 1 week
Step 13A, induction of protein production on solid medium for SDS resistance or TEM analysis: 5 d
Step 13B, induction of protein production on solid medium containing CR for colony-color phenotype or birefringence analysis: 5 d
Step 13C, induction of protein production in liquid medium for protein export-level analysis: 1 d
Step 14A, preparation of sample for filter-retention analysis to detect the presence of SDS-resistant aggregates: 1 d Steps 14B and C, preparation of sample for TEM analysis: 1 d
Step 14D, preparation of sample for CR birefringence analysis: 1 d
Step 14E, preparation of sample for protein export-level analysis: 1 d Steps 15-21, detecting the presence of SDS-resistant aggregates by the filter-retention assay: 1 d
antIcIpateD results
For each assay performed, we highly recommend including, as controls, fusion proteins that have previously been shown using C-DAG to form or not form extracellular amyloid aggregates, respectively. See
Step 11 for the controls we typically use. In Figure 3 , we show the expected results for both the positive and negative control samples when tested in each of the assays described in this protocol.
For the filter-retention assay, clogged wells should not be used for data analysis. Typically, for wells of a given POI that are clogged, the amounts of POI subsequently detected on the membrane for those corresponding wells are unpredictable and do not correlate with the fold dilution. We suggest using only data that show the expected correlation between the amounts of POI detected and the fold dilutions (Fig. 4) . coMpetInG FInancIal Interests The authors declare no competing financial interests.
